Skip to search formSkip to main contentSkip to account menu

fluzinamide

Known as: N-methyl-3-(3-(trifluoromethyl)phenoxy)-1-azetidinecarboxamide 
National Institutes of Health

Related topics

Related topics

2 relations

Narrower (1)

AHR-8559

Broader (1)

Azetidines

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
1992
1992
Pharmacokinetic and Dose Tolerability Study of ADD 94057 in Comedicated Patients with Partial Seizures
Summary: ADD 94057, a metabolite of fluzinamide, manufactured by the A. H. Robins Company, blocks chemically‐ and electrically… 
1990
1990
Pharmacodynamics and pharmacokinetics of AHR-11748, a new antiepileptic agent, in rodents
1985
1985
Pilot study of fluzinaimide (N‐methyl‐3‐[3‐(trifluoromethyl) phenoxy]‐1‐azetidinecarboxamide) in refractory partial seizures
We conducted a pilot study of Auzinamide in 15 adults with refractory partial seizures. After a baseline period, fluzinamide was… 
1984
1984
Anticonvulsant Action of Fluzinamide (AHR‐8559) on Kindled Amygdaloid Seizures
Summary: The anticonvulsant properties of fluzinamide (AHR‐8559) were evaluated in the kindled amygdaloid seizure model in rats… 
1984
1984
Simultaneous determination of fluzinamide and three of its active metabolites in plasma by high-performance liquid chromatography.
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)